Micronuclei to detect in vivo chemotherapy damage in a p53 mutated solid tumour
2003

Detecting Chemotherapy Damage in Tumors

publication Evidence: moderate

Author Information

Author(s): G Driessens, L Harsan, B Robaye, D Waroquier, P Browaeys, X Giannakopoulos, T Velu, C Bruyns

Primary Institution: Université Libre de Bruxelles

Hypothesis

This study aimed to compare induction of apoptosis and micronuclei formation after chemotherapy or radiotherapy in glioma cell lines with different p53 statuses.

Conclusion

The study found that p53 status significantly affects the induction of apoptosis and micronuclei formation in glioma cells after treatment.

Supporting Evidence

  • Apoptosis was quantified using caspase-3 activity and phosphatidylserine externalization assays.
  • Micronuclei formation was significantly higher in p53 mutated 9L cells compared to wild-type C6 cells.
  • Cisplatin and γ-irradiation caused notable DNA damage in 9L cells with mutated p53.
  • Results indicated that p53 status influences the effectiveness of chemotherapy and radiotherapy.

Takeaway

The study looked at how cancer treatments affect tumor cells, finding that some treatments cause more damage in cells with a mutated p53 gene.

Methodology

The study used in vitro and in vivo experiments on rat glioma cell lines to assess apoptosis and micronuclei formation after treatment with chemotherapy and radiation.

Limitations

The study did not quantify the time-dependent accumulation of apoptotic cells due to in vivo clearance by macrophages.

Participant Demographics

Fischer 344 rats were used in the experiments.

Statistical Information

P-Value

p<0.05

Statistical Significance

p<0.05

Digital Object Identifier (DOI)

10.1038/sj.bjc.6601163

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication